Contract facts
FederalNo full NAICS 541711 intel page yet. Browse NAICS intelligence
EXERCISE QUANTITY OPTION 5A is a federal award for National Institutes Of Health Niaid held by Pharmacology Discovery Services Taiwan, Ltd. Estimated value $38.3M ($38.3M obligated). Current period of performance ends Nov 30, 2027. Last award drew 1 bidder. Place of performance: FORT COLLINS, CO. Related solicitation NIHAO201800006.
Recompete timing
PublicCurrent PoP ends Nov 30, 2027 (467 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Incumbent footprint
Public recordPharmacology Discovery Services Taiwan, Ltd — $2.3M obligated across 15 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93020F00001?
75N93020F00001 (Exercise quantity OPTION 5a) is a National Institutes Of Health Niaid award with an estimated value of $38.3M, currently held by Pharmacology Discovery Services Taiwan, Ltd. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93020F00001?
National Institutes Of Health Niaid awarded 75N93020F00001 to Pharmacology Discovery Services Taiwan, Ltd.
Who is the incumbent on 75N93020F00001?
Pharmacology Discovery Services Taiwan, Ltd is the incumbent with $2.3M across 15 related awards in SCOUT’s public footprint. The current period of performance ends Nov 30, 2027.
When does Pharmacology Discovery Services Taiwan, Ltd’s 75N93020F00001 come up for recompete?
SCOUT tracks a period-of-performance end of Nov 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.